Böger CA - Search Results

1

Clinical management of patients receiving cell-based immunoregulatory therapy.

Hutchinson JA, Ahrens N, Riquelme P, Walter L, Gruber M, Böger CA, Farkas S, Scherer MN, Broichhausen C, Bein T, Schlitt HJ, Fändrich F, Banas B, Geissler EK. Hutchinson JA, et al. Among authors: boger ca. Transfusion. 2014 Sep;54(9):2336-43. doi: 10.1111/trf.12641. Epub 2014 Apr 4. Transfusion. 2014. PMID: 24697195 Review.

2

Everolimus in cardiac-transplant recipients.

Banas B, Böger C, Krämer B. Banas B, et al. N Engl J Med. 2003 Dec 4;349(23):2271-2; author reply 2271-2. doi: 10.1056/NEJM200312043492322. N Engl J Med. 2003. PMID: 14657441 No abstract available.

3

RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients.

Böger CA, Fischereder M, Deinzer M, Aslanidis C, Schmitz G, Stubanus M, Banas B, Krüger B, Riegger GA, Krämer BK. Böger CA, et al. Atherosclerosis. 2005 Nov;183(1):121-9. doi: 10.1016/j.atherosclerosis.2005.03.006. Atherosclerosis. 2005. PMID: 15899487

4

Cardiovascular risk estimates and risk factors in renal transplant recipients.

Krämer BK, Böger C, Krüger B, Marienhagen J, Pietrzyk M, Obed A, Paczek L, Mack M, Banas B. Krämer BK, et al. Transplant Proc. 2005 May;37(4):1868-70. doi: 10.1016/j.transproceed.2005.04.009. Transplant Proc. 2005. PMID: 15919488 Clinical Trial.

5

C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease.

Böger CA, Götz A, Stubanus M, Banas B, Deinzer M, Krüger B, Holmer SR, Schmitz G, Riegger GA, Krämer BK. Böger CA, et al. Kidney Int. 2005 Jul;68(1):217-27. doi: 10.1111/j.1523-1755.2005.00396.x. Kidney Int. 2005. PMID: 15954911 Free article.

6

Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation.

Krüger B, Schnitzbauer AA, Böger CA, Hoffmann U, Banas B, Farkas S, Schlitt HJ, Obed A, Krämer BK. Krüger B, et al. Among authors: boger ca. Transplant Proc. 2006 Apr;38(3):697-700. doi: 10.1016/j.transproceed.2006.01.032. Transplant Proc. 2006. PMID: 16647448

7

Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity.

Böger CA, Rümmele P, Mihatsch MJ, Banas B, Krämer BK. Böger CA, et al. Am J Transplant. 2006 Aug;6(8):1963-7. doi: 10.1111/j.1600-6143.2006.01381.x. Am J Transplant. 2006. PMID: 16889550 Free article.

8

Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function.

Weingart C, Leingärtner T, Bergler T, Krüger B, Böger C, Mack M, Banas B, Krämer BK. Weingart C, et al. Int J Clin Pharmacol Ther. 2006 Sep;44(9):422-7. Int J Clin Pharmacol Ther. 2006. PMID: 16995330 Clinical Trial.

9

SDF-1 expression is elevated in chronic human renal allograft rejection.

Hoffmann U, Banas B, Krüger B, Banas M, Bergler T, Böger C, Kammerl M, Obed A, Rümmele P, Segerer S, Riegger GA, Krämer BK. Hoffmann U, et al. Clin Transplant. 2006 Nov-Dec;20(6):712-8. doi: 10.1111/j.1399-0012.2006.00540.x. Clin Transplant. 2006. PMID: 17100720

10

Five-year follow-up after late conversion from calcineurin inhibitors to sirolimus in patients with chronic renal allograft dysfunction.

Krüger B, Fischereder M, Jauch KW, Graeb C, Hoffmann U, Böger CA, Banas B, Obed A, Schlitt HJ, Krämer BK. Krüger B, et al. Among authors: boger ca. Transplant Proc. 2007 Mar;39(2):518-21. doi: 10.1016/j.transproceed.2006.12.004. Transplant Proc. 2007. PMID: 17362772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page